Lavino Francesco Maria 4
4 · Nabriva Therapeutics plc · Filed Aug 26, 2019
Insider Transaction Report
Form 4
Lavino Francesco Maria
Chief Commercial Officer
Transactions
- Purchase
Ordinary Shares
2019-08-22$2.04/sh+4,800$9,780→ 15,972 total
Footnotes (1)
- [F1]The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 4,800 shares, with the reporting person's sale of 3,797 ordinary shares at a price of $2.08 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $204, representing the full amount of the profit realized in connection with the short-swing transaction.